CVS Health Corp Earnings Exceed Estimates by $0.10, Revenue Misses Projections

CVS Health Corp has announced its earnings for the second quarter, reporting an earnings per share (EPS) of $1.83, which surpasses the analyst estimate of $1.73 by $0.10. The company generated revenues of $91.2 billion during this quarter, slightly below the consensus estimate of $91.43 billion.

In terms of future guidance, CVS Health Corp projects an EPS for the fiscal year 2024 in the range of $6.40 to $6.65, compared to the analyst consensus of $6.97.

The stock price for CVS Health Corp closed at $58.34. Over the past three months, the stock has seen an increase of 4.51%, but it has decreased by 21.16% over the past year. In the last 90 days, the company experienced no positive EPS revisions but faced eight negative revisions.

According to financial analysis, CVS Health Corp maintains a “great performance” rating in terms of financial health.